Jianbo Peng is an accomplished inventor based in Drexel Hill, PA (US). He has made significant contributions to the field of clinical trial management through his innovative patents. With a total of 2 patents, his work focuses on automating processes that enhance the efficiency of clinical trials.

Latest Patents

Jianbo Peng's latest patents include "Automated identification of task items that must be completed before a clinical trial database can be locked." This patent describes an automated method for generating summary data regarding task items necessary for achieving a database lock in clinical trials. The system utilizes a processor and a database that communicates with it, containing clinical trial data and patient status. The processor defines lock criteria and automatically generates summary data based on the clinical trial data and status. Another notable patent is "Automated identification of tasks that must be completed before a clinical trial database can be locked." This invention provides a management system for database locks in clinical trials, allowing for the automatic generation of task lists based on defined lock criteria.

Career Highlights

Jianbo Peng is currently employed at Numoda Technologies, Inc., where he applies his expertise in clinical trial management. His innovative approaches have contributed to the advancement of methodologies used in clinical research.

Collaborations

Jianbo has collaborated with John W Houriet, Jr., enhancing the development of their innovative solutions in clinical trial management.

Conclusion

Jianbo Peng's contributions to the field of clinical trials through his patents demonstrate his commitment to innovation and efficiency. His work continues to impact the way clinical trials are managed, paving the way for advancements in medical research.